33 min listen
Defining and Striving for HBV Cure: What’s in the Pipeline
Defining and Striving for HBV Cure: What’s in the Pipeline
ratings:
Length:
15 minutes
Released:
Jun 30, 2022
Format:
Podcast episode
Description
In this episode, Carla S. Coffin, MD, MSc, shares her thoughts on the different investigational approaches under evaluation for their potential to achieve HBV cure, including entry inhibitors, capsid inhibitors, siRNAs, immune modulators, TLR agonists, therapeutic vaccines, and checkpoint inhibitors.Presenter:Carla S. Coffin, MD, MScProfessor of MedicineDivision of Gastroenterology and HepatologyDepartment of MedicineUniversity of CalgaryMedical Director of Calgary Liver UnitDivision of Gastroenterology and HepatologyDepartment of MedicineFoothills Medical CentreCalgary, Alberta, CanadaContent based on an online CME program supported by independent educational grants from AbbVie and Gilead Sciences, Inc. and developed in collaboration with the American Liver Foundation. Link to full program:https://bit.ly/3OGHvOv
Released:
Jun 30, 2022
Format:
Podcast episode
Titles in the series (100)
COVID-19: Answering the Questions, Part 5: In Part 5 of this ongoing 12-part COVID-19 series, listen to a brief update on the epidemiology of SARS-CoV-2 and evidence-based interventions for reducing transmission, followed by answers to critical clinician questions on COVID-19 transmission and mitigation by David Heymann, BA, MD, DTM&H. by CCO Infectious Disease Podcast